Quinoline potassium channel inhibitors

Details for Australian Patent Application No. 2004276237 (hide)

International Classifications

Event Publications

23 March 2006 PCT application entered the National Phase

PCT publication WO2005/030792 Priority application(s): WO2005/030792

21 August 2008 Application Accepted

Published as AU-B-2004276237

18 December 2008 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.